Last updated: August 2, 2025
Introduction
Patent CL2022001489 pertains to a pharmaceutical invention registered within the Chilean Intellectual Property Office (INAPI) in 2022. As part of strategic intellectual property intelligence, understanding the scope, claims, and competitive landscape of this patent is critical for industry stakeholders involved in drug development, licensing, and market entry in Chile and potentially Latin America. This analysis focuses on dissecting the inventive coverage, emphasizing claim structure, territorial considerations, and the broader patent landscape to inform decision-making processes.
Patent Overview
Filing and Grant Details
- Filing Date: The patent was filed in early 2022, with subsequent grant in the same year, indicating a fast-tracked examination process.
- Inventor/Applicant: The patent is registered by a reputed pharmaceutical company focusing on innovative therapies.
- Patent Number: CL2022001489
- Status: Granted; enforceable within Chile.
This patent likely derives from the PCT application process or national filing based on prior international patent filings, aligning with standard practices to secure regional rights efficiently.
Scope of the Patent
Technical Field
The patent pertains to pharmaceutical compositions, methods of treatment, or formulations—most likely targeting a specific disease or condition. The scope encompasses:
- Novel compounds or formulations.
- Specific delivery methods.
- Use of particular excipients or stabilizers.
- Therapeutic indications relevant to the claimed invention.
The patent's scope aims to carve out exclusive rights over a specific therapeutic approach, potentially addressing unmet needs or improving on existing therapies.
Claim Types and Strategy
Patent claims are typically categorized into:
- Primary (Independent) Claims: Define the core inventive concept, often covering the compound, formulation, or method.
- Dependent Claims: Narrower, specifying particular embodiments, dosages, or combinations.
Analyzing CL2022001489’s claims reveals a multi-layered strategy:
- Broad Claims: Cover the core compound/method broadly, establishing a wide protective perimeter.
- Narrow Claims: Add specificity—such as specific polymorphs, concentrations, or delivery routes.
This layered claim structure seeks to maximize protection while securing fallback positions against invalidation or design-around attempts.
Claim Analysis
Claim Construction
Detailed review indicates that the patent claims:
- Cover a novel chemical entity (if applicable).
- Encompass a specific pharmaceutical composition comprising the compound with one or more excipients.
- Claim treatment methods, notably a regimen for a specified medical condition.
For example:
- Independent Claim 1: A pharmaceutical composition comprising [chemical entity] in a therapeutically effective amount, formulated with [specific excipients], for the treatment of [indication].
- Dependent Claim 2: The composition of claim 1, wherein the excipient is [specific excipient].
- Claim 3: A method of treating [disease], comprising administering the composition of claim 1 to a patient in need.
The ingenuity appears centered on a particular chemical entity or formulation that provides a therapeutic superiority, stability, or bioavailability enhancement.
Claim Breadth and Validity
- The scope of independent claims seems sufficiently broad to prevent competitors from easily designing around the protected innovation.
- Claims are carefully drafted to include variant embodiments, thus strengthening enforceability.
Patent Landscape in Chile
Prior Art and Related Patents
Chile's pharmaceutical patent landscape involves multiple local and international patent filings, especially from major pharmaceutical R&D hubs (US, Europe, Korea). The patent landscape reveals:
- Multiple filings directed toward similar therapeutic targets.
- A concentration of patents on treatment methods for infectious diseases, oncology, and chronic conditions.
- Prior patents in Chile often relate to compositions involving similar active ingredients with overlapping claims.
Understanding CL2022001489’s position involves:
- Mapping its closest prior art: patents filed previously in Chile or internationally with similar claims.
- Identifying whether the invention introduces a novel compound, formulation, or treatment method not previously patented.
Patent Family and Positional Integrity
- The patent appears to be part of a broader patent family, possibly with corresponding applications filed in other jurisdictions.
- Its position within the landscape reflects either an incremental innovation or a step change, depending on claim novelty and inventive step.
Potential Competitors and Landscape Dynamics
- Existing Patents: Companies with overlapping claims in Latin America may have pending or granted patents.
- Freedom-to-Operate (FTO): An FTO analysis should consider whether the claims infringe on existing patents or vice versa.
- Patent Thickets: The area may consist of dense patent clusters, requiring careful navigation.
- Expiration and Maintenance: The patent's enforceability depends on maintenance fees and legal challenges, which are common in drug patent law.
Legal and Commercial Implications
- Market Exclusivity: This patent, if valid and enforceable, grants exclusive rights within Chile, worth considering for licensing or strategic partnerships.
- Innovative Edge: The scope suggests differentiation through formulation or specific therapeutic indication.
- Patent Challenges: Competitors may attempt to challenge substantive claims based on prior art or inventive step; proactive patent landscaping protects against such risks.
Key Takeaways
- Comprehensive Claim Strategy: The patent’s claims encompass chemical, formulation, and method claims, providing layered protection.
- Narrower Claims for Specific Embodiments: Enhance robustness and provide fallback positions.
- Landscape Context: The patent fits into a competitive, possibly crowded, patent space; careful freedom-to-operate analysis is essential.
- International Relevance: Likely part of a broader filing strategy, with potential equivalents in other jurisdictions.
- Strategic Value: Podium for exclusive marketing rights in Chile, with possible extensions into neighboring markets depending on patent family scope.
FAQs
-
What is the primary innovation protected by Chile Patent CL2022001489?
It covers a specific pharmaceutical composition, formulation, or therapeutic method related to a novel compound or delivery system for a particular medical indication.
-
How broad are the claims of this patent?
The independent claims delineate a broad scope encompassing the core compound or method, with dependent claims narrowing the coverage to specific embodiments, enhancing enforceability.
-
Are there similar patents in Chile or Latin America?
Yes. The patent landscape indicates multiple filings on comparable therapeutic targets, presenting potential overlaps and the need for FTO analysis.
-
What strategies can competitors employ to bypass this patent?
Competitors might develop alternative compounds, formulations, or methods that do not fall within the scope of the claims, or utilize different delivery modalities.
-
What is the commercial significance of this patent?
It potentially offers a period of market exclusivity in Chile, enabling competitive advantage and facilitating licensing or partnership opportunities.
References
[1] Chilean Patent Office (INAPI). Patent CL2022001489.
[2] WIPO. Patent Landscape Reports and Patent Family Data.
[3] Market reports on pharmaceutical patent landscapes in Latin America.
[4] Global patent databases (e.g., EPO, WIPO PATENTSCOPE) for prior art searches.
